Press Release: July 11, 2018
Create your Aura at Neuro Oncology Congress 2018
Conference Series LLC Ltd, host of 3rd International Conference on Neuro-Oncology and Brain Tumor. Conference that discusses the New Paradigm Approach for Innovative Techniques and Advancements in Neuro-Oncology and Neuro Pharma. It also provides an opportunity to showcase your innovation in front of the world for the global recognition. Neuro oncology 2018 is 3rd International Conference on Neuro-Oncology and Brain Tumor, show in Singapore. The event is held at Singapore, from 14-15 September 2018.
In addition, attendees will enjoy special events and lecturers featuring specialists and top scholars. It is a perfect platform for Directors, Head of Department, Professors, Industrial Researchers, Neuro-oncologist, Radiation Oncologists, Oncologists, Neuropediatricians, Neurophysiologists, Neurosurgeons, Neurologist, Neuroradiologist, Neuro-Pathologists, Rehabilitation Specialists , Nurses, Neuroscience Researchers and Students from academia in the research of Neuro-oncology, Brain tumor organizations, Neurooncology Organizations, Neuroscience, institutions, Educational institutions, Healthcare professionals, Pharmaceutical companies and industries Business delegates.
Neuro Oncology 2018, brought together the International blend of people from Neurology, pharmaceutical, biotech & medical devices companies, business entrepreneurs, Neuro pharmaceutical consultants, R&D heads and decision makers from Neuro pharmaceuticals, contract research, clinical trials, leading universities and research institutions making it the largest endeavor from Conference Series LLC Ltd. All the papers presented at this conference were published in special issue of Journal of Developing Neurology: Open Access.
• 300+ Participation (70 Industry: 30 Academia)
• 5+ Keynote Speakers
• 50+ Plenary Speakers
• 20+ Exhibitors
• 14 Innovative Educational Sessions
• 5+ Workshops
• B2B Meetings
It’s a platform to bring all the neurooncologists and Neuroscientists together to share their experiences it’s the amalgam of scientific research as well as innovative ideas.
• USD $10.5 billion in revenue in 2011.
• USD 11.1 Billion in revenue by 2012.
• USD 16.7 billion revenue by 2017.
• five-years compound annual growth rate (CAGR) of 8.5%.
• The global market for Neurooncology and brain disorder was valued at 10.5 billion in 2011 and should reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8.5%.
If you would like to know more information about this conference, Contact: Mili Biswal
For more information, please contact:
Visit the newsroom of: Neurooncology 2018